Condition: Transfusion-dependent Beta-Thalassemia · Gene Therapy · Sponsor: Institute of Hematology & Blood Diseases Hospital, China
The investigate will conduct a cohort study to compare the growth and development, metabolism, lifestyle behavior, and health-related quality of life among three groups: children with transfusion-dependent β-thalassemia (TDT) who have received gene therapy, TDT children with lifelong supportive therapy and healthy children.
This description comes directly from the study's public registry record.
Jun Shi, PhD · 2223900913 · shijun@ihcams.ac.cn
Jingyu Zhao, MPH · 13752253515 · zhaojingyu@ihcams.ac.cn
Always discuss trial participation with your own doctor first.
| Regenerative Medicine Center | Tianjin, Tianjin Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05991336